What are the facts about the use of bacteriostatic agents in WF used for parenteral products?Select all that apply. A. The addition of a bacteriostat may provide some protection from contamination of a multi-dose vial if the product is contaminated after the vial is opened and the first dose has been extracted. B. The names and proportions of antimicrobial agents used in Bacteriostatic WFI must be stated on the label. C. Bacteriostatic WFI may be used for rehydrating small volume injectables, not more than 30 ml in a vial. D. Bacteriostatic WFI is used in neonatal medicine because tiny babies are so susceptible to infection from contaminated products.

Appropriate sterile vehicles for solutions or suspensions for parenteral injection other than WFI may include which of the following?Select all that apply A. Ringer's Injection, USP B. Bacteriostatic Sodium Chloride Injection, USP C. Sodium Chloride Injection, USP D. Benzyl Alcohol

Match each term with the correct definition or description. - Biologic - Parenteral - Large volume parenteral - Bacteriostatic WFI, USP - active immunity - aural A. medical preparation up to 1000 ml intended to be administered continuously over a period of time B. protective antibodies produced as a result of exposure to a pathogen or to the antigens of a pathogen, that protect an individual on subsequent exposure to the organism C. aural preparations that may be solutions or suspensions, administered as drops D. a substance produced by a living source and used for the diagnosis, treatment, prevention or cure of disease in humans or other animals E. WFI which contains preservatives; it may be used as a sterile vehicle in the preparation of small-volume injectable products; must not be used in new borns F. dosage form intended primarily for injection into the patient, can include inhaled or ophthalmic dosage forms, too

Test performed to compare the weight or volume of a product filled into each container with their labeled weight or volume(1 Point)Water contentMinimum fillStorageall of the thesenone of theseWhich is a common biological indicator for pharmaceutical sterilization processes?(1 Point)B. subtilisC. difficileC. albicansH. influenzaeRecommended packaging of ointments:(1 Point)Collapsible tubestight containerswell-closed containersall of the thesenone of theseWhich of the following types of inert ingredients/substances is prohibited in injections?(1 Point)AntioxidantspH buffersAntimicrobial preservativesColoringsBenzyl alcoholWhich is an advantage of suspensions over solutions for ophthalmic delivery?(1 Point)Suspensions do not cause stinging or burning sensation.Suspensions provide a longer corneal contact time.Suspensions do not require a preservative.One drop of suspension is smaller than one drop of solution.The eye can hold a greater volume of suspension than solution.Which of the following technologies is an example of reverse genetics?(1 Point)Recombinant DNAPolymerase chain reactionGene insertionMurine MAbAntisense RNA

What way clinical chemistry reports the medical doctors? Antibiotic and antiseptic, which one can be used externally? In perfume industry a ‘nose’ is called -------------. By using which reagent, the common group is incorporated in explosives like TNT, Gun Cotton and RDX? What is ‘Umami’ taste? Give the other names given for MSG in sauces, soup powders and noodle’s masalas. The burning sensation of chilly is not relieved by drinking water- True/False. The maximum % of air in branded and quality ice cream should be _______. Reason out- why organic foods are costly? Molecule of happiness is ------

Which of the following is not a requirement for the packaging of sterile injectable products? A. Single dose products must be packaged in vials or ampules that contain less than 30 ml. B. A single dose container must be hermetic but once it has been opened it cannot be resealed with assurance that sterility has been maintained. C. A multi-dose container must be hermetic, but due to the packaging, the sterility of the contents is maintained to allow withdrawal of successive doses. D. The material of the container and its closure must not interact with the drug preparation in a way that alters the strength or efficacy of the product.